TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) will report first quarter 2026 financial results after market close on May 5, 2026.

The management team will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT; domestic dial-in is (800) 715-9871, international (646) 307-1963, access code 9254082. A live and archived webcast will be available on the company's Investors website.

News Market Reaction – TMDX

+5.27%

+5.27% Session close to close

In the Apr 22 session, TMDX gained 5.27%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with how...

Analysis

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with how investors sometimes anticipate upcoming earnings events, especially after prior periods of robust growth and detailed guidance. With shares trading below the 200-day MA and well under the 52-week high, a sharp move could reflect positioning ahead of the Q1 2026 release, but such pre-earnings enthusiasm has historically been sensitive to subsequent results and tax or accounting nuances.

Key Figures

Current price: $113.12 Price change 24h: -2.36% 52-week high: $156 +5 more

8 metrics

Current price $113.12 Pre-announcement trading level

Price change 24h -2.36% Move ahead of Q1 2026 earnings date news

52-week high $156 52-week trading range high

52-week low $84.53 52-week trading range low

Earnings release date May 5, 2026 Scheduled Q1 2026 financial results release

Conference call time 4:30 p.m. ET / 1:30 p.m. PT Q1 2026 earnings call start time

Domestic dial-in (800) 715-9871 U.S. access number for earnings call

Access code 9254082 Conference call access code for investors

Previous Earnings date Reports

1 past event · Latest: Feb 10 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 10	Earnings date notice	Neutral	-4.3%	Announced timing and access details for Q4 and FY 2025 earnings call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings date news on Feb 10, 2026 coincided with a -4.3% move, suggesting scheduling announcements have previously seen negative price reactions.

Recent Company History

Recent news has focused on financial communication and strong 2025 performance. The last earnings date notice on Feb 10, 2026 preceded Q4 and full-year 2025 results and coincided with a -4.3% move. Subsequent earnings on Feb 24–27 highlighted rapid revenue growth, sizable tax-related benefits, and detailed guidance. Today’s Q1 2026 earnings date continues this established cadence of regular financial disclosures and conference calls to update investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., April 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 9254082. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.   

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-first-quarter-2026-financial-results-on-may-5-2026-302748748.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) report Q1 2026 results and what time is the conference call?

TransMedics will report Q1 2026 results after market close on May 5, 2026, with a call at 4:30 p.m. ET. According to the company, management will discuss the quarter on the conference call and provide a live webcast via the Investors website.

How can investors listen to the TransMedics (TMDX) Q1 2026 earnings call on May 5, 2026?

Investors can dial (800) 715-9871 (domestic) or (646) 307-1963 (international) and enter access code 9254082. According to the company, a live and archived webcast will also be available on the TransMedics Investors website for remote listeners.

Will TransMedics (TMDX) provide a webcast of the May 5, 2026 conference call and where is it hosted?

Yes, TransMedics will provide a live and archived webcast of the May 5, 2026 call. According to the company, the webcast will be hosted in the "Investors" section of the TransMedics website at investors.transmedics.com.

What access code is required to join the TransMedics (TMDX) May 5, 2026 earnings call?

The required access code for the May 5, 2026 TransMedics call is 9254082. According to the company, callers should provide this access code when dialing the domestic or international conference numbers to join the management discussion.

What topics will TransMedics (TMDX) management likely cover on the May 5, 2026 call?

Management will present first quarter 2026 financial results and discuss business updates and outlook. According to the company, the conference call and webcast are intended to review the quarter and answer investor questions about operations and strategy.